Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lubinski

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Clinical Genetics|January 26, 2007
A survey of preventive measures among BRCA1 mutation carriers from PolandJ Gronwald, T Byrski, T Huzarski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2014
Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II studyS Delaloge, R Wolp-Diniz, T Byrski, et al.
Breast Cancer Research and Treatment|October 19, 2017
Serum selenium levels predict survival after breast cancerJ Lubinski, W Marciniak, M Muszynska, et al.
International Journal of Cancer|February 26, 2013
Xeroderma pigmentosum genes and melanoma riskK Paszkowska-Szczur, R J Scott, P Serrano-Fernandez, et al.
International Journal of Oncology|March 17, 2009
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg)P Willems, V Magri, M Cretnik, et al.
Journal of Medical Genetics|October 22, 2008
Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutationsC Cybulski, B Górski, T Huzarski, et al.
Current Oncology (Toronto, Ont.)|April 26, 2014
A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriersS A Narod, N Tung, J Lubinski, et al.
Archives of Dermatological Research|September 6, 2013
Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis riskT Dębniak, E Soczawa, M Boer, et al.
Journal of Fish Biology|March 28, 2026
Diet of juvenile skipjack herring Alosa chrysochloris: Ontogenetic shifts, predator-prey size ratios and mouth gape allometryJoshua P Egan, Peter J Hundt, Neil P Rude, et al.
British Journal of Cancer|April 30, 2009
Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in probandJ Gronwald, C Cybulski, W Piesiak, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Clinical Genetics|January 26, 2007
A survey of preventive measures among BRCA1 mutation carriers from PolandJ Gronwald, T Byrski, T Huzarski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2014
Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II studyS Delaloge, R Wolp-Diniz, T Byrski, et al.
Breast Cancer Research and Treatment|October 19, 2017
Serum selenium levels predict survival after breast cancerJ Lubinski, W Marciniak, M Muszynska, et al.
International Journal of Cancer|February 26, 2013
Xeroderma pigmentosum genes and melanoma riskK Paszkowska-Szczur, R J Scott, P Serrano-Fernandez, et al.
International Journal of Oncology|March 17, 2009
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg)P Willems, V Magri, M Cretnik, et al.
Journal of Medical Genetics|October 22, 2008
Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutationsC Cybulski, B Górski, T Huzarski, et al.
Current Oncology (Toronto, Ont.)|April 26, 2014
A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriersS A Narod, N Tung, J Lubinski, et al.
Archives of Dermatological Research|September 6, 2013
Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis riskT Dębniak, E Soczawa, M Boer, et al.
Journal of Fish Biology|March 28, 2026
Diet of juvenile skipjack herring Alosa chrysochloris: Ontogenetic shifts, predator-prey size ratios and mouth gape allometryJoshua P Egan, Peter J Hundt, Neil P Rude, et al.
British Journal of Cancer|April 30, 2009
Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in probandJ Gronwald, C Cybulski, W Piesiak, et al.
Pageof 9